K2 Nytt

[:no]We hereby invite you to attend the local symposium in the memory of Helga B. Salvesen to be held 14^th September 2016 in Store Auditorium at Haukeland University Hospital. The symposium is titled “Biomarkers in Female Cancer” and is a joint effort between CCBIO and the K2 department at UiB and Kvinneklinikken at Helse Bergen. The aim of the symposium is to honor Helgas memory by focusing on the state of the art within research on gynecologic cancer as well as younger researchers efforts within the field.

As you can see from the program (link below), we have secured international, national and local speakers. There will also be a combined lunch and poster session in the Aula of the Building for Basic Biological Research (BBB), where younger researchers can present their work. The symposium is open to all and free of charge, so please feel free to forward this invitation.

We would like to underline that all participants need to register through the below link within 8^th September 2016. Please note that after pressing “Continue” and reviewing the registration you need to press “Register”. You are not registered before you have received the confirmation.

• Registration, within 8^th September 2016: https://skjemaker.app.uib.no/view.php?id=2355656
• Program:  http://vedlegg.uib.no/?id=d321580fecd799e51bd8f8552673e51f
• Further information about CCBIO:  www.ccbio.no

Questions: To CCBIOs Administrative Leader Geir Olav Løken on geir.loken@uib.no

We hope that Helgas memorial symposium will be an inspiring event to all participants!
On behalf of CCBIO and its partners at K2 and Kvinneklinikken,[:en]We hereby invite you to attend the local symposium in the memory of Helga B. Salvesen to be held 14^th September 2016 in Store Auditorium at Haukeland University Hospital. The symposium is titled “Biomarkers in Female Cancer” and is a joint effort between CCBIO and the K2 department at UiB and Kvinneklinikken at Helse Bergen. The aim of the symposium is to honor Helgas memory by focusing on the state of the art within research on gynecologic cancer as well as younger researchers efforts within the field.

As you can see from the program (link below), we have secured international, national and local speakers. There will also be a combined lunch and poster session in the Aula of the Building for Basic Biological Research (BBB), where younger researchers can present their work. The symposium is open to all and free of charge, so please feel free to forward this invitation.

We would like to underline that all participants need to register through the below link within 8^th September 2016. Please note that after pressing “Continue” and reviewing the registration you need to press “Register”. You are not registered before you have received the confirmation.

• Registration, within 8^th September 2016: https://skjemaker.app.uib.no/view.php?id=2355656
• Program:  http://vedlegg.uib.no/?id=d321580fecd799e51bd8f8552673e51f
• Further information about CCBIO:  www.ccbio.no

Questions: To CCBIOs Administrative Leader Geir Olav Løken on geir.loken@uib.no

We hope that Helgas memorial symposium will be an inspiring event to all participants!
On behalf of CCBIO and its partners at K2 and Kvinneklinikken,[:]

[:no]Helga Bergljot Midtbø disputerer for Ph.d. graden fredag, 09. september 2016
Prøveforelesning: 09. september 2016, kl. 09:30
Oppgitt emne:  “The bearing of inflammation on cardiovascular disease. Present knowledge and future Challenges”
Place:  Stort auditorium, Haukeland Universitetssykehus
Disputas: 09. september 2016, kl. 11:15
Place:  Stort auditorium, Haukeland Universitetssykehus
Avhandlingens tittel: “Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors”
1st opponent:  Associate professor Giuseppe Schillaci, Universitetet i Perugia, Italia
2nd opponent Professor Karin Manhem, Universitetet i Gøteborg, Sverige

Pressemelding[:en]Helga Bergljot Midtbø will defend her PhD thesis on Friday, September 9th, 2016
Trial lecture: Friday, September 9th, 2016 09:30
Topic:  “The bearing of inflammation on cardiovascular disease. Present knowledge and future Challenges”
Place:  Stort auditorium, Haukeland Universitetssykehus
Public defense: Friday, September 9th, 2016 11:15
Place:  Stort auditorium, Haukeland Universitetssykehus
Title of dissertation:  “Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors”
1st opponent: Associate professor Giuseppe Schillaci, Universitetet i Perugia, Italia
2nd opponent: Professor Karin Manhem, Universitetet i Gøteborg, Sverige

Press release (in Norwegian)[:]

[:no]Course in clinical studies including ICH- Good clinical practice (GCP901) is a very relevant course for PhD students doing clinical Research
At this course you will be given a thorough introduction to:

• ICH-GCP and laws relevant to clinical research including the Health Research Act and related regulations ICH-GCP
• on the design and conduct of clinical trials and development of some applications that are relevant to clinical research
• Different units inform what they can assist with in the implementation of clinical trials
• The importance of ethical considerations in clinical trialsThe PhD course GCP901 is a 1 ECTS course part of the Bergen Postgraduate School of Clinical Medical Research. It is led by Professor Eyvind Rødahl and Professor Thomas Halvorsen. NB! This is same course which was previously called “Good clinical practice (ICH-GCP) for PhD candidates”.

Dates:
Day 1: 26th of September (half day)
Day 2: 29^th of September (whole day)
Day 3: 7th of October (half day)

Registration: at the Studentweb by 1^st of September
If you have any questions regarding the course please feel free to contact:

Course content: Eyvind Rødahl – Eyvind.Rodahl@uib.no , Thomas Halvorsen-   thomas.halvorsen@helse-bergen.no or Stefan Johansson – Stefan.Johansson@uib.no Administrative matters: Solveig Lund Witsø Solveig.Witso@uib.no[:en]Course in clinical studies including ICH-GCP (GCP901) is a very relevant course for PhD students doing clinical Research
At this course you will be given a thorough introduction to:

• ICH-GCP and laws relevant to clinical research including the Health Research Act and related regulations ICH-GCP
• on the design and conduct of clinical trials and development of some applications that are relevant to clinical research
• Different units inform what they can assist with in the implementation of clinical trials
• The importance of ethical considerations in clinical trialsThe PhD course GCP901 is a 1 ECTS course part of the Bergen Postgraduate School of Clinical Medical Research. It is led by Professor Eyvind Rødahl and Professor Thomas Halvorsen. NB! This is same course which was previously called “Good clinical practice (ICH-GCP) for PhD candidates”.

Dates:
Day 1: 26th of September (half day)
Day 2: 29^th of September (whole day)
Day 3: 7th of October (half day)

Registration: at the Studentweb by 1^st of September
If you have any questions regarding the course please feel free to contact:

Course content: Eyvind Rødahl – Eyvind.Rodahl@uib.no , Thomas Halvorsen-   thomas.halvorsen@helse-bergen.no or Stefan Johansson – Stefan.Johansson@uib.no Administrative matters: Solveig Lund Witsø Solveig.Witso@uib.no[:]

Cytostatikaboken i ny utgave kan bestilles fra Bjørg Algerøy (bjorg.algeroy@helse-vest.no) tlf 72070.
Boken vil koste kr. 450,-

 

[:no]I forbindelse med vårt nye Illumina HiSeq4000 dyp-sekvenseringssystem vil Genomikk kjernefasiliteten invitere til NGS applikasjonsseminar torsdag 8 september.

Tid: 8 September, 13.00-16.00
Sted: Møterom 5.1/5.2 i 5 etg i Laboratoriebygget.

Vennligst se invitasjon here for mer informasjon og registrering til seminaret.[:en]Regarding our new Illumina HiSeq4000 next-generation sequencing system the Genomics Core Facility is happy announce a NGS application seminar Thursday September 8^th.

Time: September 8^th, 13.00 – 16.00.
Place: Meeting room 5.1/5.2, 5^th floor Laboratory building.

Please see the invitation here for more information on the program and for registration to the seminar.[:]

[:no]Vi har gleden av å invitere alle til neste K1/K2 seminar tirsdag 30.august.

Grant Brinkworth -PhD, associate professor, University of South Australia, Adelaide, Australia
Principal Research Scientist at CSIRO – Food and Nutrition, Adelaine, AUS
Long-term health and safety effects of Very Low Carbohydrate Diets for Type 2 Diabetes Management:
Current clinical practice guidelines for type 2 diabetes management advocate a diet low in fat and high in unrefined carbohydrates. However, this recommendation has been questioned following advancements in understanding that carbohydrate restriction and higher intakes of protein and unsaturated fat improve blood glucose control and cardiovascular disease risk.
This presentation will discuss the findings of a large, long-term, well-controlled, randomized controlled clinical study comparing the effects of either a traditional high-carbohydrate diet or a very-low-carbohydrate, high-unsaturated-fat diet while participating in a structured exercise program on multiple health outcomes, including glycemic control, cardiovascular disease risk, renal function, and mental wellbeing and performance.
Findings indicate that independent of any change in weight, the blood glucose profile improves substantially in the very-low-carbohydrate group. The diet is well tolerated and the need for medication is also reduced to a greater extent than the traditional high-carbohydrate dietary approach.
Tid: Tirsdag 30. August 14.30-15:30
Sted: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Simon Dankel, Dep. Of Clinical Science, UiB

Pizza serveres fra 14:15-14.30.
Everyone is welcome!

 [:en]We wish to invite you all to the next K1/K2 Seminar in 2016. Tuesday August 30th!

Grant Brinkworth -PhD, associate professor, University of South Australia, Adelaide, Australia
Principal Research Scientist at CSIRO – Food and Nutrition, Adelaine, AUS
Long-term health and safety effects of Very Low Carbohydrate Diets for Type 2 Diabetes Management:
Current clinical practice guidelines for type 2 diabetes management advocate a diet low in fat and high in unrefined carbohydrates. However, this recommendation has been questioned following advancements in understanding that carbohydrate restriction and higher intakes of protein and unsaturated fat improve blood glucose control and cardiovascular disease risk.
This presentation will discuss the findings of a large, long-term, well-controlled, randomized controlled clinical study comparing the effects of either a traditional high-carbohydrate diet or a very-low-carbohydrate, high-unsaturated-fat diet while participating in a structured exercise program on multiple health outcomes, including glycemic control, cardiovascular disease risk, renal function, and mental wellbeing and performance.
Findings indicate that independent of any change in weight, the blood glucose profile improves substantially in the very-low-carbohydrate group. The diet is well tolerated and the need for medication is also reduced to a greater extent than the traditional high-carbohydrate dietary approach.

Time: Tuesday August 30th, 14:30 – 15:30
Pace: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Simon Dankel, Dep. Of Clinical Science, UiB

Pizza is served between 14:15 -14:30
Everyone is welcome.

 [:]

[:no]Årets felles undervisningsdag for K1 og K2 holdes 12.Oktober 2016 på VilVite senteret.
Programmet for dagen finner du here. Trykk here for å melde deg på dagen.

 [:en]This year’s teaching day for K1 and K2 will be held October 12th 2016 at the VilVite center in Bergen.
The program for the day can be found here. Click here to sign up for the day[:]

[:no]I forbindelse med den årlige Scandinavian Conference in Cardiothoracic Surgery i Reykjavik 17.-19.august i år, var vår PhD-kandidat cand.med. Terje Aass nominert og vant prisen «C. Walton Lillehei, Ph.D., M. D. Young Investigators Award» på $5000 for sitt foredrag:

 Myocardial energy status and ultrastructure with polarizing and depolarizing             cardioplegic arrest in a porcine model. 

Terje Aass er overlege ved Thoraxkirurgisk seksjon, Hjerteavdelingen, Haukeland Universitetssykehus, og arbeider også med et doktorgradsprosjekt knyttet til Hjerteforskningsgruppen ved K2. Prosjektet er en dyreeksperimentell studie av en ny kardioplegiløsning som brukes for å stanse hjertet og beskytte myokard ved åpne hjerteoperasjoner der en bruker hjerte-lunge maskin.
Walton Lillehei, en amerikansk hjertekirurg med norske aner, betegnes internasjonalt som den åpne hjertekirurgiens far.[:en]In connection with the annual Scandinavian Conference in Cardiothoracic Surgery in Reykjavik August 17th -19th of this year, our PhD candidate cand.med. Terje Aass nominated and won the award «C. Walton Lillehei, Ph.D., M. D. Young Investigators Award «of $ 5,000 for his lecture:

Myocardial energy status and ultrastructure with polarizing and depolarizing cardioplegia arrest in a porcine model.

Terje Aass is chief physician at Thoracic Surgery Section, Department of Cardiology, Haukeland University Hospital, and is also working on a PhD project related to Cardiovascular Research Group at K2. The project is an animal experimental study of a new kardioplegiløsning used to stop the heart and protect myocardium by open heart surgery in which a user heart-lung machine.
Walton Lillehei, an American heart surgeon with Norwegian idea, termed internationally as the open hjertekirurgiens father.[:]